Optomed Oyj (HEL:OPTOMED)
2.610
+0.070 (2.76%)
At close: Mar 4, 2026
Optomed Oyj Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 9.91 | 10.47 | 7.12 | 8.52 | 6.8 |
Cash & Short-Term Investments | 9.91 | 10.47 | 7.12 | 8.52 | 6.8 |
Cash Growth | -5.33% | 47.05% | -16.50% | 25.28% | -35.86% |
Accounts Receivable | 2.76 | 2.41 | 2.58 | 3.56 | 3.66 |
Other Receivables | 0.12 | 0.14 | 0.1 | 0.22 | 0.17 |
Receivables | 2.88 | 2.55 | 2.68 | 3.78 | 3.82 |
Inventory | 2.38 | 1.96 | 2.82 | 3 | 2.94 |
Prepaid Expenses | 0.6 | 0.72 | 0.51 | 0.79 | 0.81 |
Other Current Assets | - | -0 | - | - | - |
Total Current Assets | 15.77 | 15.7 | 13.13 | 16.09 | 14.37 |
Property, Plant & Equipment | 2.11 | 2.11 | 2.18 | 2.3 | 1.64 |
Goodwill | 4.26 | 4.26 | 4.26 | 4.26 | 4.26 |
Other Intangible Assets | 1.09 | 1.42 | 1.76 | 2.08 | 2.38 |
Long-Term Deferred Tax Assets | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 |
Long-Term Deferred Charges | 8.74 | 8.29 | 7.73 | 6.56 | 6.34 |
Other Long-Term Assets | 0 | - | - | - | 0 |
Total Assets | 31.97 | 31.78 | 29.08 | 31.3 | 29 |
Accounts Payable | 1.16 | 0.89 | 0.78 | 0.87 | 0.94 |
Accrued Expenses | 2.66 | 2.35 | 1.96 | 1.94 | 1.58 |
Current Portion of Long-Term Debt | 1.06 | 0.99 | 0.99 | 0.99 | 1.26 |
Current Portion of Leases | 0.44 | 0.5 | 0.52 | 0.41 | 0.4 |
Current Unearned Revenue | 0.04 | 0.01 | - | - | - |
Other Current Liabilities | 1.23 | 0.85 | 0.81 | 1.02 | 0.73 |
Total Current Liabilities | 6.59 | 5.58 | 5.05 | 5.23 | 4.91 |
Long-Term Debt | 0.37 | 1.31 | 2.36 | 4.29 | 5.75 |
Long-Term Leases | 0.84 | 1.02 | 0.99 | 1.06 | 0.82 |
Long-Term Deferred Tax Liabilities | 0.16 | 0.23 | 0.31 | 0.39 | 0.46 |
Other Long-Term Liabilities | 0 | -0 | 0 | - | - |
Total Liabilities | 7.96 | 8.14 | 8.72 | 10.96 | 11.95 |
Common Stock | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
Additional Paid-In Capital | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
Retained Earnings | -42.65 | -36.56 | -31.49 | -27.19 | -21.97 |
Comprehensive Income & Other | 66.08 | 59.61 | 51.27 | 46.95 | 38.44 |
Shareholders' Equity | 24.02 | 23.64 | 20.36 | 20.34 | 17.05 |
Total Liabilities & Equity | 31.97 | 31.78 | 29.08 | 31.3 | 29 |
Total Debt | 2.71 | 3.81 | 4.86 | 6.74 | 8.23 |
Net Cash (Debt) | 7.2 | 6.66 | 2.26 | 1.78 | -1.43 |
Net Cash Growth | 8.13% | 194.56% | 26.90% | - | - |
Net Cash Per Share | 0.36 | 0.36 | 0.14 | 0.12 | -0.11 |
Filing Date Shares Outstanding | 21.43 | 19.66 | 17.78 | 16.17 | 13.58 |
Total Common Shares Outstanding | 21.43 | 19.66 | 17.78 | 16.17 | 13.58 |
Working Capital | 9.17 | 10.11 | 8.08 | 10.86 | 9.46 |
Book Value Per Share | 1.12 | 1.20 | 1.15 | 1.26 | 1.26 |
Tangible Book Value | 18.67 | 17.96 | 14.35 | 14.01 | 10.42 |
Tangible Book Value Per Share | 0.87 | 0.91 | 0.81 | 0.87 | 0.77 |
Machinery | 4.63 | 4.02 | 3.72 | 3.51 | 2.72 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.